Goa freedom struggle animated series to begin production in Aug '25
An animated web series on Goa's historic freedom struggle will begin production in Aug 2025, said minister for archives and archaeology, Subhash Phal Dessai, in an unstarred long answer question (LAQ) on Monday at the monsoon assembly session.
'The primary objective behind the production is to create interest among the youth about the history of Goa's liberation,' Phal Dessai stated in his replies. The project will feature 26 episodes, each running for 10-12 minutes. The animated video production will offer viewers an engaging fusion of motion graphics, 2D, and 3D animation techniques.
'The telecast or public viewing of the web series will be approximately from Jan 26, 2026, onwards,' he said.
Chief minister Pramod Sawant announced in his budget speech this year that an animated series on the Goa freedom struggle and the lives of its freedom fighters is expected to be released soon.
In a separate LAQ, Phal Dessai said the directorate of archaeology's plans to digitise archival records from 1530 CE onwards. 'After digitisation, it will be easy for the research scholars to access and apply for the relevant records online,' he said.
Besides primary sources, the department's library offers digitised secondary sources, such as rare books (1697-1960), Gazettes (1841 CE onwards), and books on legislation (1901-1961), and photocopies of relevant publications are provided. It has also published 25 research journals and 9 available seminar volumes. In 2023-24, two books, 'Saunsthanachya Itihasachin Sadhane' (Khand II) by the Transcriber of Records and 'Portuguese Hukumnama' by Ratnakar Desai, were released.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges
Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed second-quarter earnings picture, with adjusted earnings surpassing analyst consensus but overall sales experiencing a slight year-over-year decline and missing revenue expectations. The market's cautious reaction underscores investor scrutiny of the company's performance, particularly a significant drop in Gardasil vaccine sales, even as its blockbuster cancer drug Keytruda continued its strong growth trajectory. While adjusted earnings per share (EPS) of $2.13 surpassed consensus estimates of $2.04, it marked a decline from the $2.28 reported in the prior-year period. Similarly, total sales of $15.81 billion, a 2% year-over-year decrease, narrowly missed analysts' projections of $15.94 pharmaceutical segment recorded $14.1 billion in sales, down 2% year over year, primarily due to vaccines and immunology, partially offset by growth in oncology and cardiology. Keytruda, an immunotherapy for cancer, delivered $7.96 billion in global sales, up 9% year-over-year, reflecting continued uptake across more cancer types and earlier treatment stages. However, GARDASIL and GARDASIL 9, vaccines to prevent HPV-related diseases, generated $1.1 billion in sales, down 55% compared to last year. The company cited lower demand in China. Excluding China, sales declined 3%, or 4% excluding the impact of foreign exchange, reflecting lower demand in Japan following a national catch-up immunization program, as well as the timing of public-sector purchases in certain international markets. U.S. sales increased 2% in the quarter. The diabetes franchise, led by JANUVIA and JANUMET, remained mostly flat at around $623 million, with a slight 1% sales decrease. Newer products, including Winrevair sales, a therapy for pulmonary arterial hypertension (a rare heart-lung condition), saw accelerated sales since its launch, reaching $336 million compared to $70 million a year ago. CAPVAXIVE, a 21-valent pneumococcal conjugate vaccine, saw $129 million in sales, representing continued uptake since the third-quarter 2024 launch in the U.S. View more earnings on MRK Animal Health sales increased 11% to $1.65 billion, primarily due to higher demand for Livestock products, the inclusion of sales from the Elanco aqua business acquired in July 2024, higher pricing, and improved supply. Restructuring Program Merck launched a new multiyear optimization initiative to enable the transformation of its portfolio by generating an expected $3.0 billion in annual cost savings. The company anticipates cumulative pretax costs related to the program to be approximately $3.0 billion. For the second quarter of 2025, the company recorded charges in its GAAP results of $649 million related to this restructuring program. Merck expects the actions under the restructuring program to result in annual cost savings of approximately $1.7 billion, which will be substantially realized by the end of 2027. This restructuring program is part of the multiyear optimization initiative expected to achieve $3.0 billion in annual cost savings by the end of 2027. Manufacturing and R&D Investment Merck continued to make long-term investments in its U.S. manufacturing and R&D capabilities, including the start of construction for a $1.0 billion, 470,000-square-foot state-of-the-art biologics center in Wilmington, Delaware, which will serve as a launch and commercial production facility and the primary U.S. manufacturing site for Keytruda. In addition, the company announced an $895 million expansion of its Animal Health manufacturing facility in De Soto, Kansas, to increase capacity for Animal Health vaccines and biologic products. Guidance Merck raises its fiscal 2025 adjusted earnings guidance from $8.82-$8.97 to $8.87-$8.97 compared to the consensus estimate of $8.90. The company also narrowed its 2025 sales guidance from $64.1 billion-$65.6 billion to $64.3 billion-$65.3 billion versus the consensus of $65.01 billion. The $200 million of costs previously included in the company's financial outlook related to the impact of tariffs is unchanged pending the outcome of additional potential government actions. During the earnings conference call, Merck's CEO addressed the potential impact of EU tariffs, stating that immediate implementation would have a minimal effect on 2025 results. However, the timing of these tariffs and their connection to the Section 232 investigation remain unclear. Simultaneously, Merck revealed it will not resume Gardasil shipments to China through at least the end of this year. This decision comes as Gardasil channel inventories in China remain elevated and demand continues to be soft. Furthermore, the company anticipates that Japan will experience a 'more significant headwind' in terms of growth for Gardasil in the second half of the year. Price Action: MRK stock is trading lower by 6.19% to $78.86 at last check Tuesday. Read Next:Photo by Tada Images via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? MERCK & CO (MRK): Free Stock Analysis Report This article Merck CEO Sees Minimal EU Tariffs Impact, Warns Of Gardasil Challenges originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Sign in to access your portfolio
Yahoo
4 minutes ago
- Yahoo
Wall Street's New Bitcoin Darling Says It'll Be "The Berkshire Hathaway of The Bitcoin Ecosystem" — Will it Actually Happen?
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Wall Street's new Bitcoin darling has declared a lofty goal for the firm: becoming 'the Berkshire Hathaway (NYSE:BRK, BRK.B)) of the Bitcoin ecosystem." 'We're really trying to create a fortress-like environment for our Bitcoin and really trying to position ourselves as the Berkshire Hathaway of the Bitcoin ecosystem,' Bitcoin Standard Treasury Company investment chief Sean Bill told Bloomberg last week. Don't Miss: — no wallets, just price speculation and free paper trading to practice different strategies. Grow your IRA or 401(k) with Crypto – . The new firm, which will serve as the latest Bitcoin proxy for Wall Street speculators, is not the only one that has declared this ideal. 'We're going to be one of the major players in the space where I look at us as kind of the Berkshire Hathaway of Bitcoin treasury companies,' Strive Asset Management CEO Matt Cole said in May. But what does becoming the Berkshire Hathaway of the Bitcoin ecosystem or Bitcoin treasury companies mean? In the traditional finance world, Berkshire Hathaway is a symbol for all the ideals that most companies aspire to, from integrity to corporate discipline and long-term shareholder value growth. This reputation has come with several benefits. For one, the firm has its pick of acquisition deals as businesses line up to be included in its portfolio. At the same time, it also allows the firm to command favorable terms in credit markets. Trending: New to crypto? on Coinbase. These elements would be critical for a firm looking to become the dominant player in the Bitcoin treasury ecosystem. But attaining such heights is no walk in the park. Bitwise Head of Alpha Strategies Jeff Park said in June that the Berkshire Hathaway of Bitcoin would have to master three return on equity strategies, including liability, asset and operating equity management. But that's not all. 'Becoming the 'lender of last resort' for the global Bitcoin economy is both a privilege and responsibility that will demand flawless execution,: he said. 'But to truly earn this honor, a fourth element is essential. If 'never sell your Bitcoins' is the ethos, then leadership must also embody Bitcoin's culture for the long term. It must unapologetically back Bitcoin development, supporting the community over the corporate, and invest its spiritual weight alongside its financial.'Park said no single firm checked all the boxes at the time. Until such a firm arises, MicroStrategy (NASDAQ:MSTR), the pioneer of the Bitcoin treasury strategy, remains the dominant player. At last look, the firm holds nearly 608,000 BTC worth over $71 billion, roughly 3% of all Bitcoin that will ever exist. By comparison, Bitcoin Standard Treasury Company intends to launch with just over 30,000 BTC worth $3.5 billion, making it the fourth-largest Bitcoin treasury. But according to Bill, the firm plans to quickly rise to the second spot, displacing MARA Holdings (NASDAQ:MARA), which holds 50,000 BTC on its balance sheet. Read Next: 7,000+ investors have joined Timeplast's mission to eliminate microplastics— Image: Imagn Images This article Wall Street's New Bitcoin Darling Says It'll Be "The Berkshire Hathaway of The Bitcoin Ecosystem" — Will it Actually Happen? originally appeared on Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Mavericks new team president Ethan Casson vows to make fan outreach 'one of my biggest priorities'
The Dallas Mavericks have a new team president. The team reportedly hired former Minnesota Timberwolves CEO Ethan Casson in the role, according to Sports Business Journal. The move will reportedly allow current Mavericks CEO Rick Welts to focus on securing a new arena for the team. Casson and Welts have a history together, and the two rekindled their relationship after it became clear Casson was going to leave the Timberwolves with new owners Alex Rodriguez and Marc Lore taking over the team. In his role as team president, Casson will be more focused on day-to-day operations of the team, according to SBJ. Welts will work on "big strategic priorities." The two will be involved with what the other person is doing, but Casson said the partnership would be more of a "divide and conquer kind of arrangement." Handling day-to-day operations for the Mavericks could prove to be challenging. While the team picked up Duke standout Cooper Flagg with the No. 1 overall pick in the 2025 NBA Draft, it still has work to do to win back the fanbase. Mavericks fans are still frustrated with the organization — particularly general manager Nico Harrison — over the shocking trade that sent Luka Dončić to the Los Angeles Lakers. Casson specifically called out fan outreach as one of his top priorities in an interview with SBJ. 'I'm going to make [healing the fans] literally one of my biggest priorities, if not the most important priority," he said. Casson added that he would 'listen, listen, listen and listen' to Mavericks fans, and vowed to "meet fans where they are," per the SBJ. 'I'll describe it this way: I want to meet fans where they are,' Casson said. 'So if they're in the 'We're enthusiastic about the future' mode, great. Tell me why and how we can continue to enhance that enthusiasm. And if you're in the camp of 'I'm still really disappointed, I can't believe this happened,' great. I'm going to meet you where you are. Tell us how we change that on your behalf?" This story will be updated.
